The best way to heal

  • Description
  • Benefits
  • Indications
  • In Practice
  • FAQs
  • Evidence
  Download product information

Discover UrgoStart Border

Adhesive foam dressing with soft-adherent TLC-NOSF

  • Heals twice as fast as a neutral dressing (1) and avoids wounds becoming longstanding
  • Is cost-effective
  • Improves patients’ quality of life (1)
    Now available in a waterproof silicone adhesive version for greater convenience

Composition

UrgoStart Border is an adhesive foam dressing with soft-adherent TLC-NOSF, comprised of :

  • A soft-adherent TLC-NOSF layer combined with an absorbent polyurethane foam pad and a highly absorbent layer
  • A waterproof outer film with silicone adhesive only on the edges

 

urgostart-border-description-02

 

Mode of action

TLC (Technology Lipido-Colloid) combined with NOSF (Nano-Oligo Saccharide Factor) is a patented innovative technology which in contact with wound exudate forms a gel and creates a moist environment enabling the key cells involved in the repair process (fibroblasts, keratinocyrtes, macrophages) to exert their action.

TLC-NOSF interacts with the wound micro-environment of the wound by preventing the detrimental effect of Matrix Metallo Proteases (MMPs) which in excess in chronic wounds creates a continuous degradation of the extra-cellular matrix. TLC-NOSF restores balance in the wound bed so granulation of chronic wounds can occur. UrgoStart Border thereby promotes faster wound healing.

TLC NOSF Technology

 
 * Studies on pathophysiological mechanisms in healing have demonstrated the essential role of proteases (MMPs) in the persistence of inflammatory responses and the slowing of wound healing (2, 3, 4, 5). Proteases are enzymes that participate in the physiological wound cleansing process; they help set the stage for healing. However, when subcutaneous tissue is ischaemic, for example in arterial disease or diabetes, the presence of proteases becomes excessive, causing persistent inflammation and dermal destruction (2). This excess of proteases has been observed in leg, pressure and diabetic foot ulcers, the three major types of chronic wounds (2,3,4,5).
 
(1) Meaume S, et al.A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers. Wound Repair and Regeneration 2012 (July/August);Vol 20:500-511.
(2) Kirsner et al. Wounds, 2002,vol 13, N°3, May/june,
(3) R Lobmann. Diabetologia 2002 ; 45:1011–1016
(4) Y Liu. Diabetes Care 2009; 32:117–9
(5) A Moore. Wound Rep Regen 2009;17:832-39

This website is an international website. Some products or sizes can therefore be unavailable in some countries. For more information, please contact us.

Benefits for the wound

  • Heals twice as fast as a neutral foam dressing (1)
  • Avoids wounds becoming longstanding with associated risks of complications
  • Neutralisation of excess proteases
  • High vertical absorption (greater absorption capacity than Mepilex/Allevyn)
  • Moist wound healing
  • Fibroblast proliferation
  • No adherence to the wound (no damage to newly formed tissue)
  • Protection and improvement of peri-wound skin
  • High conformability to the wound bed

benefits-for-professionnalBenefits for health professionals

  • Heals twice as fast as a neutral foam dressing (1)
  • Avoids wounds becoming longstanding with associated risks of complications
  • Highly convenient dressing
  • Cost effective treatment
  • Improves patient quality of life: less anxiety, less depression, less pain (1)
  • High exudate management (high absorbency)
  • Easy to apply
    • Stays in place when applied
    • Easy to reposition
  • Easy to remove with pain-free dressing changes
  • Very conformable to different wound shapes
  • Can be used under compression

benefits-for-patientBenefits for patients

  • Faster recovery (1)
  • Avoids wounds becoming longstanding with associated risks of complications
  • Very convenient : allows bathing or showering
  • Improved patient quality of life: less anxiety, less depression, less pain (1)
  • No adherence to the wound: pain-free dressing changes
  • Well tolerated
  • Very conformable and comfortable

(1) Meaume S, et al.A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers. Wound Repair and Regeneration 2012 (July/August);Vol 20:500-511.

UrgoStart Border is indicated for the treatment of moderately to heavily exuding chronic wounds (leg ulcers, pressure ulcers, diabetic foot ulcers, longstanding acute wounds).

The sacral version is recommended for moderately to heavily exuding chronic wounds located in the sacral area (sacral pressure ulcers…).

Contraindications

In order not to delay any optimal treatment, UrgoStart Border is contraindicated in wounds such as cancerous wounds or fistula wounds which may reveal a deep abscess.

Do not use if there is a known sensitivity to UrgoStart Border.

Instructions for use

  • Clean the wound as per local protocol and rinse with normal saline.
  • If an antiseptic is first used, rinse the wound thoroughly with saline solution before applying UrgoStart Border.
  • Dry carefully the surrounding skin.
  • Using the tabs, remove the protective film.
  • Apply the soft-adherent side of UrgoStart Border to the wound (the adhesive silicone border should be at least 1 cm away from the wound)
  • Smooth the dressing over the wound.
  • Apply compression bandaging over the dressing when prescribed.
  • UrgoStart Border may be changed every 2 to 4 days and left in place depending on the exudate level and the clinical condition of the wound.
  • The recommended treatment duration is a minimum of 8 weeks until wound healing.

Application of the sacrum version:

  • Place the dressing with the tip facing the sacral area

Precautions for use

  • As it includes a highly-absorbent layer, the central pad should not be cut. However, the adhesive edges can be cut if necessary to fit the dressing to different wound shapes.
  • As the soft adherent layer of UrgoStart Border adheres to surgical gloves (latex), it is recommended to manipulate the dressing avoiding contact with the coated layer.
  • If signs of critical colonisation are present, suitable treatment is recommended prior to the use of UrgoStart Border.
  • In case of an atypical ulcer presenting induration or overgranulation, UrgoStart Border should only be used after checking the absence of wound-related malignancy in order not to delay the diagnosis.
  • The action of the product on the healing process may possibly cause stinging or painful sensations at the start of the treatment with UrgoStart Border. This rarely warrants suspension of treatment.
  • In the absence of clinical data as a first line treatment in acute wounds, and in the treatment of Epidermolysis bullosa (even for longstanding lesions), it is not recommended to use UrgoStart Border.
  • Any excess hair should be cut close to the skin to ensure good contact with the wound.
  • Discard any unused parts of the dressing.
  • Check that the sterility protector is intact before use.
  • Single-use, individual and sterile dressing: re-using a single-use product may lead to risks of infection.
  • Do not re-sterilise the dressing.

urgostart_border_8x8Sizes available

  • 8×8 cm
  • 10×10 cm; 12×12 cm; 13×13 cm
  • 15×15 cm; 15×20 cm
  • Sacrum 20×20 cm

 

 


This website is an international website. Some products or sizes can therefore be unavailable in some countries. For more information, please contact us.

Product

What is UrgoStart Border?

UrgoStart Border is an adhesive foam dressing with soft-adherent TLC-NOSF, comprising a TLC-NOSF layer combined with an absorbent polyurethane foam pad and a highly absorbent layer, and a waterproof outer film with silicone adhesive on the edges.

How does UrgoStart Border work?

TLC (Technology Lipido-Colloid) combined with NOSF (Nano-Oligo Saccharide Factor) is a patented innovative technology which in contact with wound exudate forms a gel and creates a moist environment enabling the key cells involved in the repair process (fibroblasts, keratinocyrtes, macrophages) to exert their action.

TLC-NOSF interacts with the wound micro-environment of the wound by preventing the detrimental effect of Matrix Metallo Proteases (MMPs) which in excess in chronic wounds creates a continuous degradation of the extra-cellular matrix. TLC-NOSF restores balance in the wound bed so granulation of chronic wounds can occur. UrgoStart Border thereby promotes faster wound healing.

What is the role of the soft-adherence?

The soft-adherence makes UrgoStart Border very conformable and flexible, ensuring close contact with the wound bed to promote healing.

Why do you say that UrgoStart Border is cost-effective?

Due to improved healing rates, UrgoStart Border reduces overall treatment time, and therefore the number of nurse visits and the associated costs.

Indications

When should I use UrgoStart Border?

UrgoStart Border is indicated for the treatment of moderately to heavily exuding chronic wounds (leg ulcers, pressure ulcers, diabetic foot ulcers, longstanding acute wounds …).

Can I use UrgoStart Border during the epithelialisation stage?

Yes.

Can I use UrgoStart Border in desloughing stage?

For desloughing, UrgoClean is recommended as the best option.

Can I use UrgoStart Border on infected wounds?

In the case of an infected wound, an antibacterial dressing should be used before using UrgoStart Border.

What are the contraindications of UrgoStart Border?

In order not to delay any optimal treatment, UrgoStart Border is contraindicated in wounds such as cancerous wounds or fistula wounds which may reveal a deep abscess.

Do not use if there is a known sensitivity to UrgoStart Border.

Use

Can I cut UrgoStart Border?

As it includes a super-absorbent layer, the central pad should not be cut. However, the adhesive edges can be cut if necessary to fit the dressing to different wound shapes.

Can I use UrgoStart under compression?

Yes.

Can I shower with UrgoStart Border on?

Yes, the outer film is waterproof.

When should I change UrgoStart Border?

UrgoStart Border should be changed every 2 to 4 days depending on the level of exudate and the clinical condition of the wound. The transparent outer film allows better monitoring fluid strikethrough and only changing the dressing when needed.

The wound seems larger after treatment with UrgoStart Border. Is this to be expected?

It has been demonstrated that the wound may initially appear larger after treatment with UrgoStart Border, before reducing in size. Continuing treatment with UrgoStart Border is essential to promote faster healing.

My patient complains with pain/stinging, is this to be expected?

In some cases, this has been noted during the initial stages. However, if the patient is able to tolerate it, continued treatment with UrgoStart Border is essential to promote faster healing.

Evidence

What evidence do you have?

The efficacy of TLC-NOSF has been clinically proven in:

  • A Double blind Randomised Controlled Trial demonstrating that it heals twice as fast as a neutral foam dressing
  • A randomized Controlled Trial (with the contact layer version – UrgoStart Contact)
  • Observational studies
  • Several clinical studies on leg ulcers, pressure ulcers and diabetic foot ulcers

Clinical evidence

UrgoStart range has been evaluated in numerous European clinical studies involving patients with different types of wounds, in particular leg ulcers, pressure ulcers and diabetic foot ulcers.

Its clinical efficacy has been demonstrated for venous or mixed predominantly venous ulcers in two comparative controlled clinical studies, one vs Promogran and another, the Challenge study, vs a neutral dressing.

 

Urgo_Review_resize_A4_web    
Supporting evidence-based practice: a clinical review of TLC technology    
Download    
Last update : November 23, 2017